Figure 1.

Value at baseline (BL), after 1 year of growth hormone (GH) treatment (V1), and 1 year of GH treatment + testosterone treatment (V2) for selected parameters. EF, ejection fraction; NT‐pro BNP, serum amino terminal fragment of the pro‐hormone brain type natriuretic peptide; NYHA, New York Heart Association; VO2,: oxygen consumption. * P < 0.01 respect BL; ^ P < 0.01 V2 respect V1.